People

Hendrik P.N. Scholl
Hendrik P.N. Scholl is named Investment Advisory Board in Droia’s current public directory. The published professional background includes M.D. University of Tübingen; Professor and Chairman of the Department of Ophthalmology, University of Basel; Founding and Scientific Director of the Institute of Molecular and Clinical Ophthalmology Basel (IOB); Retinal specialist with expertise in translational research in ophthalmology, especially gene therapy. This is a manager-published affiliation; advisory-board membership and Droia Labs scientific roles are qualified separately from the investment team. Exact appointment dates and personal cash participation are not inferred.
Roles
Droia Ventures
CurrentInvestment Advisory Board